Engineering firm reveals pilot-scale bioreactor system for cell cultivation and precision fermentation.
Dusseldorf, Germany-based engineering firm GEA on Wednesday revealed its new perfusion platform, which promises to support the production of alternative proteins and provide significant cost savings.
Developed for pilot projects, the platform includes a continuously operating bioreactor and a single-use separator, creating a closed, sterile system…
Join for free* to continue reading.
You’ll get access to all Alt-Meat has to offer including full access to our web content devoted to the meat alternatives market.
Already a member? Click here to login>>.
*Free for qualified recipients